Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NOTA-RM26 PET/CT in GIST
NCT05001204Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2021
- Primary completion
- Aug 2022
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label trial of 68Ga-NOTA-RM26 in gastrointestinal stromal tumor (GIST), sponsored by Peking Union Medical College Hospital. Primary endpoint: Standardized uptake value at 1 year. Status: unknown.
02
Drugs
68Ga-NOTA-RM26
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT05001204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05001204.